Results 211 to 220 of about 62,013 (267)

Hepatobiliary disorders associated with TNF-α inhibitors: a pharmacovigilance analysis of FAERS and JADER. [PDF]

Front Immunol
Chen H, Jiang S, Wang J, Zhang A, Zhu L.
europepmc   +1 more source

Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized Therapy. [PDF]

Biomedicines
Marafini I, Salvatori S, Fonsi A, Monteleone G.   +3 more
europepmc   +1 more source

Chronic Productive Cough in an Immunosuppressed Patient due to Biologics: A Rare Case of <i>Bordetella bronchiseptica</i> Pulmonary Infection. [PDF]

Respirol Case Rep
Banerjee D, Ayaz E, Hudson A, Trainor E, Vijayakumar B, Bandara H.   +5 more
europepmc   +1 more source

Posterior Reversible Encephalopathy Syndrome After Infliximab Infusion for Fistulizing Crohn's Disease

Qusay Abdoh, Razan Rabi, Basel Musmar, Ahmad Abuhassan, Abdulkareem Barqawi   +4 more
openalex   +1 more source

Outcomes of an Intravenous to Subcutaneous Infliximab (CT-P13) Strategy in Takayasu Arteritis: A Proof-of-Concept Prospective Study. [PDF]

ACR Open Rheumatol
Iorio L, Davanzo F, Fiorin E, Codirenzi M, Prevedello R, Doria A, Padoan R.   +6 more
europepmc   +1 more source

Utilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review. [PDF]

BMJ Open Gastroenterol
Quraishi MN, Alahmad MA, Sharara AI, Trivedi PJ, Al-Bawardy B, Alrubaiy L.   +5 more
europepmc   +1 more source

Research on gamma globulin unresponsive Kawasaki disease: A review. [PDF]

World J Clin Pediatr
Wu ZC, Pan Y.
europepmc   +1 more source

Pyoderma Gangrenosum with Biological Agents Therapy: A Systematic Review. [PDF]

Clin Cosmet Investig Dermatol
Tan B, Chen M, Hu X, He J, Zhang L, Du S, Mou Y, Xiong X, Duan X.   +8 more
europepmc   +1 more source